"/> Novus Biologicals™ Peptide bloquant d’anticorps KA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps KA2/GRIK5/Glutamate Receptor KA2

Réf. : BL-RE-048812Réf. fabricant : 18268515
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
2901
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76853. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 17 amino acids near the carboxy terminus of human Grik5.

Points forts

Source

Synthetic

(Accession #: NP_002079) The KA2/GRIK5/Glutamate Receptor KA2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-048812
Réf. fabricant18268515
Gene ID (Entrez)2901
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76853. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneEAA2, Excitatory amino acid receptor 2, glutamate receptor KA2, Glutamate receptor KA-2, glutamate receptor, ionotropic kainate 5, glutamate receptor, ionotropic, kainate 5, KA2GRIK2
Symbole de gène(s)GRIK5
Type de produitKA2/GRIK5/Glutamate Receptor KA2
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne17 amino acids near the carboxy terminus of human Grik5
Une question, une configuration particulière ?
Contactez-nous pour un devis.